anaphylaxis anaphylaxis
Conditions
Interventions
None listed
Sponsors
Takazawa Tomonori
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who were included in this study between January 1, 2019 and December 31, 2021
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Seeking the optimum concentrations of drugs for in vitro tests. | — |
Secondary
| Measure | Time frame |
|---|---|
| Exploring the methods which improve the accuracies of in vitro tests. | — |
Contacts
Public ContactTomonori Takazawa
Gunma University Hospital
Outcome results
None listed